Focus: Spineart is a Swiss medical device company specializing in spinal implants for musculoskeletal disorders. The company focuses on innovative solutions for spinal disease and cervical disc pathology.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
5 added, 4 removed. Backfill posture.
Best suited for early-to-mid career professionals seeking niche medical device expertise in spinal implants, with awareness that company scale and financial health remain opaque.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Post-market surveillance program with 2-year prospective follow-up data supporting clinical efficacy.
Help build intelligence for Spineart
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Spineart's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Cervical disc replacement device with ongoing clinical trials supporting commercial adoption.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles